Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase EARLY_PHASE1 × Carcinoma, Intraductal, Noninfiltrating × gadoterate meglumine × Clear all

Phase

Phase EARLY_PHASE1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Fibroadenoma 1 Carcinoma, Intraductal, Noninfiltrating 1 Breast Neoplasms 1 Breast Diseases 1

Interventions

pembrolizumab 1 gadoterate meglumine 1 Mifepristone 1 Mastectomy, Simple 1 Ferric Oxide, Saccharated 1 Biopsy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04341129 2023-12-05

Abbreviated MRI Protocol: Initial Experience With Dotarem® (Gadoterate Meglumine)

University of Chicago

Phase EARLY_PHASE1 Completed

Breast Diseases, Breast Neoplasms, Carcinoma, Intraductal, Noninfiltrating, Fibroadenoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡